Key facts
- GAGNON SECURITIES LLC filed SCHEDULE 13G/A for Treace Medical Concepts, Inc. Common stock, $0.001 par value (TMCI).
- Disclosed ownership: 9.6%.
- Date of event: 31 Dec 2025.
GAGNON SECURITIES LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Treace Medical Concepts, Inc. Common stock, $0.001 par value (TMCI)
- Filing Manager
- GAGNON SECURITIES LLC
- Reporting Manager
- Neil Gagnon
- Symbol
- TMCI
- Shares outstanding
- 63,980,281 shares
- Disclosed Ownership
- 6,142,107 shares
- Ownership
- 9.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Feb 2026, 17:57:53 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 15 May 2025
- SEC
- View on sec.gov
Key filing fact
GAGNON SECURITIES LLC disclosed 9.6% ownership in Treace Medical Concepts, Inc. Common stock, $0.001 par value (TMCI) on 31 Dec 2025.
Change
- Previous schedule filing date: 15 May 2025.
- Current filing was accepted on 12 Feb 2026, 17:57.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Gagnon Securities LLC | 6.2% | 3,928,051 | 0 | 3,389,401 | /s/ Neil Gagnon | Neil Gagnon/Chief Executive Officer | |
| Gagnon Advisors, LLC | 2.4% | 1,534,034 | 0 | 1,534,034 | /s/ Neil Gagnon | Neil Gagnon/Managing Member | |
| Neil Gagnon | 9.6% | 6,142,107 | 420,406 | 5,155,905 | /s/ Neil Gagnon | Neil Gagnon |
CIK / CUSIP context first